On the Menu:

How to Optimize your Pre-IND Meeting

Boston Marriott Cambridge
50 Broadway, Cambridge, MA 02142
Friday, October 25th from 8:30 to 10:00 a.m.

For many emerging biotech companies, the Pre-IND Meeting is the first encounter with FDA. The importance of this meeting cannot be overstated; the difference between a mediocre and a great Pre-IND Meeting is measured in years of time and millions of dollars in development. We have conducted hundreds of successful Pre-IND Meetings on behalf of our clients.
Join us for breakfast on Friday, October 25th as we discuss the ways to optimize your time with the FDA and how to get the approval process started in the EU.

Presentation and Discussion by:

Matthew Weinberg

CEO, The Weinberg Group & VP, Global Regulatory Affairs, ProPharma Group

Steve Jensen

EVP, Head of Regulatory Consulting

Dr. Colin Wheeler, MBChB, FFPM, DPM

CEO, Southwood Research & VP, European Regulatory Affairs, ProPharma Group